SCHEMBL31419673

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C

nearest known ligand 0.63

Predicted protein targets (top 2)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	19/20	0.63

▸	VIPR1	P32241	1/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31182816	0.93	GLP1R (0.69)	GLP1RVIPR1
SCHEMBL30903287	0.92	GLP1R (0.58)	GLP1RVIPR1
SCHEMBL29716050	0.92	GLP1R (0.62)	GLP1R
SCHEMBL30495588	0.92	CALCR (0.64)	GLP1RVIPR1
SCHEMBL30176463	0.92	GLP1R (0.70)	GLP1RVIPR1
SCHEMBL30431788	0.90	GLP1R (0.61)	GLP1R
SCHEMBL29649225	0.90	GLP1R (0.65)	GLP1RVIPR1
SCHEMBL30262196	0.89	VIPR1 (0.65)	GLP1RVIPR1
SCHEMBL31182481	0.89	GLP1R (0.68)	GLP1RVIPR1
SCHEMBL31182541	0.89	GLP1R (0.66)	GLP1RVIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250092120-A1	ANTICANCER PEPTIDE AND USE IN TREATING CANCER	A.T. STILL UNIVERSITY	2025-03-20	—	—	US	disclosed